Contributing Member of the Legal, Economic & Regulatory Affairs Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

Government Run Health Insurance Fails

October 9, 2009

Analysis of:Fate of Government-Run Health Insurance May Rest in Obama's Hands | www.foxnews.com

The Senate Finance Committee rejected the "public option" for government-run health insurance not once but twice. Even some democrats were wary of the public option. These failures underscore the fact that the United States is wrestling with a fundamental shift in thinking about the proper role of government in the health care insurance business.

FTY720 for Relapsing forms of MS

October 9, 2009

Analysis of:Two-year Phase III study shows Novartis oral MS therapy FTY720 significantly reduces relapses and disability progression | www.pipelinereview.com

Fingolimod must be doing something right, because the latest study shows significant reduction in disability progression and relapse rates, even at the small doses tested (0.5 mg/d). Novartis is poised to submit an IND at the end of 2009 (very soon). The results of the FREEDOMS trial suggest that fingolimod is very effective in addressing the common indicators of therapeutic efficacy. Long-term studies will be required to further explore potential side effects and to document the extent of long-term benefit.

Page : 11 to 2 of 2

Request a News Analysis

Subscribe to Updates

By RSS